Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target.

Feng X, Bai X, Ni J, Wasinger VC, Beretov J, Zhu Y, Graham P, Li Y.

Front Oncol. 2019 Jun 27;9:557. doi: 10.3389/fonc.2019.00557. eCollection 2019.

2.

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission-confounded by the gut microbiome?

Leong RWL, Kaakoush NO, Yau YY, Wasinger VC.

Aliment Pharmacol Ther. 2019 Apr;49(8):1086-1087. doi: 10.1111/apt.15171. No abstract available.

PMID:
30920041
3.

Analysis of the Preserved Amino Acid Bias in Peptide Profiles of Iron Age Teeth from a Tropical Environment Enable Sexing of Individuals Using Amelogenin MRM.

Wasinger VC, Curnoe D, Bustamante S, Mendoza R, Shoocongdej R, Adler L, Baker A, Chintakanon K, Boel C, Tacon PSC.

Proteomics. 2019 Mar;19(5):e1800341. doi: 10.1002/pmic.201800341. Epub 2019 Feb 18.

PMID:
30650255
4.

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases.

Lee JY, Wasinger VC, Yau YY, Chuang E, Yajnik V, Leong RW.

Proteomes. 2018 Mar 31;6(2). pii: E17. doi: 10.3390/proteomes6020017. Review.

5.

Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Mourad FH, Yau Y, Wasinger VC, Leong RW.

Dig Dis Sci. 2017 Sep;62(9):2266-2276. doi: 10.1007/s10620-017-4673-0. Epub 2017 Jul 17. Review.

PMID:
28717845
6.

Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.

Chang J, Leong RW, Wasinger VC, Ip M, Yang M, Phan TG.

Gastroenterology. 2017 Sep;153(3):723-731.e1. doi: 10.1053/j.gastro.2017.05.056. Epub 2017 Jun 8.

PMID:
28601482
7.

Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.

Yau YY, Leong RWL, Pudipeddi A, Redmond D, Wasinger VC.

Mol Cell Proteomics. 2017 Jul;16(7):1244-1257. doi: 10.1074/mcp.M116.066506. Epub 2017 May 10.

8.

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.

Chang L, Ni J, Beretov J, Wasinger VC, Hao J, Bucci J, Malouf D, Gillatt D, Graham PH, Li Y.

Sci Rep. 2017 Feb 22;7:41834. doi: 10.1038/srep41834.

9.

Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620.

Cochran BJ, Hou L, Manavalan AP, Moore BM, Tabet F, Sultana A, Cuesta Torres L, Tang S, Shrestha S, Senanayake P, Patel M, Ryder WJ, Bongers A, Maraninchi M, Wasinger VC, Westerterp M, Tall AR, Barter PJ, Rye KA.

Diabetes. 2017 Feb;66(2):560. doi: 10.2337/db17-er02b. Epub 2016 Dec 1. No abstract available.

10.

Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism.

Cochran BJ, Hou L, Manavalan AP, Moore BM, Tabet F, Sultana A, Cuesta Torres L, Tang S, Shrestha S, Senanayake P, Patel M, Ryder WJ, Bongers A, Maraninchi M, Wasinger VC, Westerterp M, Tall AR, Barter PJ, Rye KA.

Diabetes. 2016 Dec;65(12):3610-3620. Epub 2016 Oct 4. Erratum in: Diabetes. 2017 Feb;66(2):560.

11.

Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Chan PP, Wasinger VC, Leong RW.

World J Gastrointest Pathophysiol. 2016 Feb 15;7(1):27-37. doi: 10.4291/wjgp.v7.i1.27. Review.

12.

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling.

You J, Willcox M, Fitzgerald A, Schiller B, Cozzi PJ, Russell PJ, Walsh BJ, Wasinger VC, Graham PH, Li Y.

Anal Biochem. 2016 Mar 1;496:30-4. doi: 10.1016/j.ab.2015.12.006. Epub 2015 Dec 21.

PMID:
26717899
13.

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y.

PLoS One. 2015 Nov 6;10(11):e0141876. doi: 10.1371/journal.pone.0141876. eCollection 2015.

14.

Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.

Wasinger VC, Yau Y, Duo X, Zeng M, Campbell B, Shin S, Luber R, Redmond D, Leong RW.

Mol Cell Proteomics. 2016 Jan;15(1):256-65. doi: 10.1074/mcp.M115.055095. Epub 2015 Nov 3.

15.

Reverse-polynomial dilution calibration methodology extends lower limit of quantification and reduces relative residual error in targeted peptide measurements in blood plasma.

Yau YY, Duo X, Leong RW, Wasinger VC.

Mol Cell Proteomics. 2015 Feb;14(2):441-54. doi: 10.1074/mcp.M114.040790. Epub 2014 Dec 9.

16.

A standardized and reproducible urine preparation protocol for cancer biomarkers discovery.

Beretov J, Wasinger VC, Schwartz P, Graham PH, Li Y.

Biomark Cancer. 2014 Nov 3;6:21-7. doi: 10.4137/BIC.S17991. eCollection 2014.

17.

Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases.

Yau YY, Leong RW, Shin S, Bustamante S, Pickford R, Hejazi L, Campbell B, Wasinger VC.

Discov Med. 2014 Sep;18(98):113-24.

18.

In vivo localization of antibodies raised against Eimeria maxima wall forming bodies during sexual intracellular development.

Frölich S, Shahparee A, Wasinger VC, Wallach M.

Parasitology. 2014 Nov;141(13):1726-35. doi: 10.1017/S0031182014001012. Epub 2014 Jul 30.

PMID:
25075563
19.

Proteomics for breast cancer urine biomarkers.

Beretov J, Wasinger VC, Graham PH, Millar EK, Kearsley JH, Li Y.

Adv Clin Chem. 2014;63:123-67. Review.

PMID:
24783353
20.

Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.

Kim PY, Tan O, Diakiw SM, Carter D, Sekerye EO, Wasinger VC, Liu T, Kavallaris M, Norris MD, Haber M, Chesler L, Dolnikov A, Trahair TN, Cheung NK, Marshall GM, Cheung BB.

J Proteomics. 2014 Jan 16;96:1-12. doi: 10.1016/j.jprot.2013.10.032. Epub 2013 Nov 4.

Supplemental Content

Loading ...
Support Center